目的应用两步凝胶色谱法制备高纯度、高安全性的人凝血酶原复合物(PCC)制剂。
Purpose to establish the preparation procedure of human prothrombin complex concentrate (PCC) by using two-step gel chromatography to obtain high purity and high security product.
目的：制备结合凝血酶原复合物(PCC)的阴离子脂膜微泡，评价微泡的理化性质。
Purpose: the purpose of this study is to prepare prothrombin complex concentrate (PCC) conjugated anionic lipid microbubbles and to assess the physiochemical properties of the microbubbles.
目的通过对国产人凝血酶原复合物(PCC)质量的研究，建立与国际接规的质量标准。
PurposeTo study on the quality of human prothrombin complex concentrate so as to establish the same quality standard as the international standard of PCC.
优化了CG - 6型大孔阴离子交换树脂从人血浆中吸附和分离凝血酶原复合物的工艺条件。
Technical conditions for adsorption and separation of prothrombin complex concentrates from human plasma with CG-6 macroporous anion-exchange resin were optimized.
结论：联合应用冷沉淀与凝血酶原复合物在创伤性失血患者治疗中，联合输注组比单独输注组疗效更显著。
Conclusion: Combination of cryoprecipitate and prothrombin complex concentrate for traumatic hemorrhage has better effects than cryoprecipitate or prothrombin complex concentrate alone.
考察了其对血浆中总蛋白和凝血酶原复合物的吸附情况及吸附等温线，以及影响凝血酶原复合物活性的因素。
The adsorption behaviors and adsorption isothermals of total proteins and prothrombin complex concentrates and the effect factors on activity of prothrombin complex concentrates were investigated.
硼硅玻璃模制注射剂瓶、溴化丁基橡胶塞包装。 1套/盒。 1套包含人凝血酶原复合物1瓶，人凝血酶原复合物溶解液1瓶。
[Packaging] Borosilicate glass vial, sealed with bromobutyl rubber stopper, packaging of 1 set per carton. 1 set contains a vial of human prothrombin complex, and solution.
方法采用酶联免疫分析法测定凝血酶原片段1+2 （F1+2 ）、纤维蛋白肽A（FPA）、可溶性纤维蛋白单体复合物（SFMC） ；
Methods Prothrombin fragments 1 and 2 (F1+2), fibrinopeptide A (FPA), soluble fibrin monomer complex(SFMC) were examined by enzyme linked immunoassay(ELISA);
方法采用酶联免疫分析法测定凝血酶原片段1+2 （F1+2 ）、纤维蛋白肽A（FPA）、可溶性纤维蛋白单体复合物（SFMC） ；
Methods Prothrombin fragments 1 and 2 (F1+2), fibrinopeptide A (FPA), soluble fibrin monomer complex(SFMC) were examined by enzyme linked immunoassay(ELISA);
应用推荐